Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Research-Use Labelling and Canadian Compliance Requirements Canadian regulatory framing for injectable peptides has tightened throughout 2025 and 2026, and BPC-157 in particular has been named in multiple Health Canada advisories
People recovering from injury or surgery BPC-157 or KLOW for tissue healing + NAD+ for cellular energy = supporting your body's repair process from two angles
Think of it this way: if your body is like a factory that produces healing and repair, most treatments work by bringing in outside materials or temporarily fixing problems
Documented symptomatic hypoglycemia (glucose of 70 mg/dL or less) was reported in 16.7% to 29.8% of patients receiving semaglutide, and severe or blood glucose confirmed symptomatic hypoglycemia (glucose of 56 mg/dL or less) was reported in 8.3% to 10.7% of patients receiving semaglutide
Thompson, K., & Davis, R
Bottom line: For a 10 mg vial of tirzepatide, 1 mL of bacteriostatic water is the standard diluent amount, resulting in a concentration of 1 mg per 10 units on a U-100 syringe
US$ 25.76
US$ 27.22
US$ 21.98
